| Literature DB >> 22980390 |
Ahmed Samir Al-Naaimi1, Atallah Mekhlef Turky, Hanan Abdulghafoor Khaleel, Rasha Waleed Jalil, Olah A Mekhlef, Susan Abdul Kareem, Nadia Yousif Hasan, Azhar Abdulla Dhadain.
Abstract
BACKGROUND: Viral hepatitis is an important preventable infectious disease with various rates of occurrence in different areas of the world. The main objective of the present study was to evaluate the role of some risk factors in predicting a positive acute viral hepatitis marker among patients with suspected acute viral hepatitis in a primary health care setting in Baghdad. Besides, finding out the occurrence of jaundice, contribution of viruses A and E to the cases that have occurred in Baghdad province was also searched for.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22980390 PMCID: PMC4776970 DOI: 10.5539/gjhs.v4n5p172
Source DB: PubMed Journal: Glob J Health Sci ISSN: 1916-9736
Relative frequency of positive anti-HAV and HEV among suspected cases
| Total suspected cases =2,692 | N | % | 95% confidence interval |
|---|---|---|---|
| Anti-HAV antibodies | 1,206 | 44.8 | (42.9% - 46.7%) |
| Anti-HEV antibodies | 42 | 1.6 | (1.1% – 2.1%) |
The risk of positive anti-HAV antibodies by selected explanatory variables
| Total | Anti-HAV antibodies | OR | 95% CI for OR | P | ||
|---|---|---|---|---|---|---|
| N | N | % | ||||
| <0.001 | ||||||
| less than 5 yrs | 406 | 262 | 64.5 | 17.37 | (9.03 – 33.39) | <0.001 |
| 5-14 yrs | 1186 | 761 | 64.2 | 17.09 | (9.08 – 32.17) | <0.001 |
| 15-44 yrs | 981 | 171 | 17.4 | 2.02 | (1.06 – 3.83) | 0.02 |
| more than 45 yrs | 116 | 11 | 9.5 | Reference | ||
| 0.024 | ||||||
| Female | 1223 | 519 | 42.4 | Reference | ||
| Male | 1466 | 686 | 46.8 | 1.19 | (1.02 - 1.39) | |
| <0.001 | ||||||
| Negative | 2315 | 1110 | 47.9 | 2.96 | (2.27 - 3.87) | |
| Positive | 329 | 78 | 23.7 | Reference | ||
| 0.003 | ||||||
| Negative | 2105 | 980 | 46.6 | 1.34 | (1.11 - 1.61) | |
| Positive | 565 | 223 | 39.5 | Reference | ||
| 0.011 | ||||||
| Negative | 2609 | 1187 | 45.5 | 2.06 | (1.17 - 3.64) | |
| Positive | 59 | 17 | 28.8 | Reference | ||
| <0.001 | ||||||
| Negative | 2576 | 1179 | 45.8 | 2.30 | (1.44 - 3.65) | |
| Positive | 93 | 25 | 26.9 | Reference | ||
| <0.001 | ||||||
| Negative | 2443 | 1136 | 46.5 | 2.02 | (1.5 - 2.72) | |
| Positive | 223 | 67 | 30 | Reference | ||
| <0.001 | ||||||
| Negative | 2602 | 1197 | 46 | 7.30 | (3.33 - 16.04) | |
| Positive | 67 | 7 | 10.4 | Reference | ||
| <0.001 | ||||||
| Negative | 2214 | 1056 | 47.7 | 1.91 | (1.54 - 2.38) | |
| Positive | 437 | 141 | 32.3 | Reference | ||
| <0.001 | ||||||
| Alkarkh | 1199 | 600 | 50 | 1.47 | (1.26 - 1.71) | |
| Alrusafa | 1493 | 606 | 40.6 | Reference | ||
Discriminant analysis model with selected independent variables and results of serum anti-HAV antibodies test as the dependent variables
| Predictors | Coefficient |
|---|---|
| Age group | 0.916 |
| Past history of jaundice | 0.334 |
| History of tattoo or cupping | 0.237 |
| Past history of Dentist visit | 0.233 |
| Primary Health Care Department | 0.23 |
| Past Surgical History | 0.167 |
| History of chronic illness | 0.136 |
| History of jaundice in the contacts | 0.132 |
| History of blood transfusion | 0.093 |
| Gender | -0.09 |
Note: *Coefficient: Pooled within-groups correlations between discriminating variables and standardized canonical discriminant functions.
Forward selection method for Discriminant analysis model with selected independent variables and results of serum anti-HAV antibodies test as the dependent variables
| Selected independent variables | Coefficients used in the discriminant equation |
|---|---|
| Age group (coded as 1 for <5 yrs, 2 for 5-14 yrs, 3 for 15-44 yrs and 4 for 45+ yrs) | 1.253 |
| History of tattoo or cupping(coded as 1 for positive and zero for negative) | 0.746 |
| Past history of jaundice(coded as 1 for positive and zero for negative) | 0.738 |
| Primary Health Care Department (coded as 1 for Alrusafa and zero for Alkarkh) | 0.475 |
| History of jaundice in the contacts(coded as 1 for positive and zero for negative) | 0.322 |
| Gender (coded as 1 for male and zero for female) | -0.204 |
| (Constant) | -3.213 |
| Negative Anti-HAV antibodies | 0.447 |
| Positive Anti-HAV antibodies | -0.54 |
| Critical value | -0.0465 |
P (model)<0.001
The risk of positive anti-HEV antibodies by selected explanatory variables
| Total N | Anti-HEV N | Antibodies % | OR | 95% CI for OR | P | |
|---|---|---|---|---|---|---|
| Age groups | <0.001 | |||||
| less than 5 yrs | 406 | 2 | 0.5 | Reference | ||
| 5-14 yrs | 1186 | 9 | 0.8 | 1.54 | (0.33 – 7.18) | 0.58[NS] |
| 15-44 yrs | 981 | 29 | 3 | 6.15 | (1.46 – 25.91) | 0.005 |
| more than 45 yrs | 116 | 1 | 0.9 | 1.76 | (0.16 – 19.55) | 0.64[NS] |
| 0.51[NS] | ||||||
| Female | 1223 | 17 | 1.4 | Reference | ||
| Male | 1466 | 25 | 1.7 | 1.23 | (0.66 - 2.29) | |
| 0.19[NS] | ||||||
| Negative | 2315 | 34 | 1.5 | Reference | ||
| Positive | 329 | 8 | 2.4 | 1.67 | (0.77 - 3.64) | |
| 0.97[NS] | ||||||
| Negative | 2105 | 33 | 1.6 | Reference | ||
| Positive | 565 | 9 | 1.6 | 1.02 | (0.48 - 2.14) | |
| 0.94[NS] | ||||||
| Negative | 2609 | 41 | 1.6 | Reference | ||
| Positive | 59 | 1 | 1.7 | 1.08 | (0.15 - 7.99) | |
| 0.65[NS] | ||||||
| Negative | 2576 | 40 | 1.6 | Reference | ||
| Positive | 93 | 2 | 2.2 | 1.39 | (0.33 - 5.85) | |
| 0.05[NS] | ||||||
| Negative | 2443 | 35 | 1.4 | Reference | ||
| Positive | 223 | 7 | 3.1 | 2.23 | (0.98 - 5.08) | |
| 0.35[NS] | ||||||
| Negative | 2602 | 40 | 1.5 | Reference | ||
| Positive | 67 | 2 | 3 | 1.97 | (0.47 - 8.33) | |
| 0.20[NS] | ||||||
| Negative | 2214 | 32 | 1.4 | Reference | ||
| Positive | 437 | 10 | 2.3 | 1.60 | (0.78 - 3.27) | |
| 0.25[NS] | ||||||
| Alkarkh | 1199 | 15 | 1.3 | Reference | ||
| Alrusafa | 1493 | 27 | 1.8 | 1.45 | (0.77 - 2.75) | |
Discriminant analysis model with selected independent variables and results of serum anti-HEV antibodies test as the dependent variables
| Predictors | Coefficient |
|---|---|
| Age group | 0.817 |
| Past Surgical History | 0.52 |
| Past history of Dentist visit | 0.335 |
| Primary Health Care Department | 0.304 |
| History of tattoo or cupping | 0.235 |
| Past history of jaundice | 0.223 |
| Gender | 0.203 |
| History of chronic illness | 0.119 |
| History of jaundice in the contacts | -0.06 |
| History of blood transfusion | 0.039 |
Note: * Coefficient: Pooled within-groups correlations between discriminating variables and standardized canonical discriminant functions
Forward selection method for Discriminant analysis model with selected independent variables and results of serum anti-HEV antibodies test as the dependent variables
| Selected independent variables | Coefficients used in the discriminant equation |
|---|---|
| Age group (coded as 1 for <5 yrs, 2 for 5-14 yrs, 3 for 15-44 yrs and 4 for 45+ yrs) | 1.293 |
| (Constant) | -2.972 |
| Negative Anti-HEV antibodies | -0.008 |
| Positive Anti-HEV antibodies | 0.529 |
| Critical value | 0.2605 |
P (model)<0.001
The rate of anti-HAV and HEV antibodies positive tests among suspected cases by seasonal variation
| Total suspected cases | Anti-HAV antibodies | Anti-HEV antibodies | |||
|---|---|---|---|---|---|
| Seasonal distribution | N | N | % | N | % |
| Summer | 394 | 169 | 42.9 | 7 | 1.8 |
| Winter | 572 | 374 | 65.4 | 6 | 1 |
| Spring | 408 | 161 | 39.5 | 5 | 1.2 |
| Autumn | 301 | 148 | 49.2 | 2 | 0.7 |
| Accuracy of prediction for negative test results | 73.5% |
| Accuracy of prediction for Positive test results | 67.5% |
| Overall Accuracy of prediction | 70.8% |
| Accuracy of prediction for negative test results | 100% |
| Accuracy of prediction for Positive test results | 0% |
| Overall Accuracy of prediction | 98.5% |